News

All Categories

12 April 2022

Tech gold rush continues as $2bn VC funding push hits the street

22 February 2022

Investment Notes: Kepler Analytics

01 February 2022

Vale Grant Chamberlain

AFR, Announcement

18 November 2021

E-bike subscription service Zoomo raises $60M Series B to disrupt last-mile delivery

10 November 2021

Victorian startups will soon be able to pitch themselves to one of Australia’s leading VC firms as part of a $30 million government initiative

10 November 2021

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021

19 October 2021

Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

14 October 2021

Blade Therapeutics Announces FDA Orphan Drug Designation Granted to Cudetaxestat for Treatment of Systemic Sclerosis

10 October 2021

Blade Therapeutics Mourns the Passing of General Counsel and Secretary Alan C. Mendelson

07 October 2021

Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease

10 September 2021

OneVentures launches new Responsible Investment Policy, putting the company’s money where the future is

28 September 2021

LiveTiles has its sights set on growth with $10m loan

27 September 2021

LiveTiles secures $10m debt facility to drive strategic growth

21 September 2021

Investment Notes: Flippa

20 September 2021

Selling a company as easy as posting an eBay listing

20 September 2021

Flippa raises $11M to match online asset and business buyers, sellers

31 August 2021

OneVentures takes VC industry lead on ESG investment and oversight

25 July 2021

Tech sector demands a plan to escape lockdown crisis

25 July 2021

Forget unicorns, OneVentures has a start-up dragon

24 July 2021

Permanent Artificial Hearts Are Closer Than You Think

07 July 2021

‘Just like Netflix’: Southern Cross backs AI start-up

04 July 2021

Hivery scores debt from OneVentures in 10th credit deal

08 June 2021

QLD govt commits $20m to vaccine manufacturer

02 June 2021

Preclinical studies from Vaxxas and Collaborators Reveal Potential of Vaxxas’ Novel High-Density Microarray Patch (HD-MAP) to Effectively Deliver SARS-CoV-2 Spike Vaccine

decor decor decor
decor decor decor decor decor